Cargando…

Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation

BACKGROUND: The safety of pharmacotherapy in atrial fibrillation (AF) is compounded by a trilogy of risks old age, high-risk medications (e.g., antithrombotics, antiarrhythmics), polypharmacy due to multiple patient comorbidities. However, to date, scarce study has investigated the use of polypharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang., Yishen, Singh., Shamsher, Bajorek., Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930859/ https://www.ncbi.nlm.nih.gov/pubmed/27382425 http://dx.doi.org/10.18549/PharmPract.2016.02.706

Ejemplares similares

Defining ‘elderly’ in clinical practice guidelines for pharmacotherapy
por: Singh, Shamsher, et al.
Publicado: (2014)

The border trilogy /
por: McCarthy, Cormac, 1933-
Publicado: (1999)

Geometric trilogy
por: Borceux, Francis
Publicado: (2014)

The counter-clock trilogy
por: O'Brien MacDonald, Shane
Publicado: (2015)

Risk of left atrial appendage thrombus in older patients with atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2021)

High-Risk Medication Use and Polypharmacy in Older Veterans Who Attempt Suicide
por: Morin, Ruth, et al.
Publicado: (2020)

The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing
por: Huang, Yun-Ting, et al.
Publicado: (2021)

Songs from the trilogy Einstein on the beach, Satyagraha, Akhnaten /
por: Glass, Philip
Publicado: (1989)

Teaching medicine through film: Wiseman's medical trilogy revisited
por: Wijdicks, Eelco F. M.
Publicado: (2019)

The body machines: futurica trilogy 3
por: Bard, Alexander, et al.
Publicado: (2012)

Changes in medicine prescription following a medication review in older high-risk patients with polypharmacy
por: Hurmuz, Marian Z. M., et al.
Publicado: (2018)

Optimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012–2013
por: Bajorek, Beata V., et al.
Publicado: (2016)

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2020)

Polypharmacy or medication washout: an old tool revisited
por: Hoffman, Daniel A, et al.
Publicado: (2011)

Trilogy-Constrained Acetabular Component for Recurrent Dislocation
por: Andersen, Annette Vest, et al.
Publicado: (2013)

Trilogy of sequential infections in a diabetic male
por: Dogra, Vikas, et al.
Publicado: (2015)

Principles of Diagnosis, Prognosis and Treatment: A Trilogy
Publicado: (1939)

Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Gut–Kidney–Heart: A Novel Trilogy
por: Caldarelli, Mario, et al.
Publicado: (2023)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
por: Gallagher, Celine, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
por: Guo, Xueyuan, et al.
Publicado: (2022)

Educational Needs of People Living with Atrial Fibrillation: A Qualitative Study
por: Ferguson, Caleb, et al.
Publicado: (2022)

A complicated trilogy: persistent left superior vena cava with hypertrophic cardiomyopathy and atrial septal defect
por: Kocabas, Umut, et al.
Publicado: (2016)

Visit-to-visit SBP variability and risk of atrial fibrillation in middle-aged and older populations
por: Wang, Chi, et al.
Publicado: (2022)

Trilogy of LHC Higgs Cross Section Working Group
por: Tanaka, R
Publicado: (2013)

Polypharmacy in the Older Adult: Medication Review in the Community
por: Pacetti, Staci, et al.
Publicado: (2020)

Frailty and the Risk of Polypharmacy in the Older Person: Enabling and Preventative Approaches
por: Nwadiugwu, Martin C.
Publicado: (2020)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation
por: Takamoto, Kojiro, et al.
Publicado: (2021)

Automated Detection of Patients at High Risk of Polypharmacy including Anticholinergic and Sedative Medications
por: Shirazibeheshti, Amirali, et al.
Publicado: (2023)

Concurrent Coronary, Left Ventricle, and Cerebral Thrombosis – A Trilogy
por: Bhandari, Monika, et al.
Publicado: (2022)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

Swiss LithoClast® Trilogy Lithotripter for Use in Robotic Pyelolithotomy
por: Levy, Micah, et al.
Publicado: (2023)

Management of Patients with Atrial Fibrillation: Specific Considerations for the Old Age
por: Haegeli, Laurent M., et al.
Publicado: (2011)

Recent Updates on Risk and Management Plans Associated with Polypharmacy in Older Population
por: Alshanberi, Asim Muhammed
Publicado: (2022)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2020)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
por: Alberts, Mark J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0kb9iq2bui5apmhjjli20onbcv